Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (341-350 of 495) with videos related to

Pageof 50
Sort By:
Urologic Oncology|April 4, 2020
Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancerTill Eichenauer, Luca Simmendinger, Martina Kluth, et al.
Oncotarget|March 23, 2019
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancerTill Eichenauer, Mohammad Hussein, Claudia Hube-Magg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 13, 2019
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancerFranziska Büscheck, Maciej Zub, Asmus Heumann, et al.
Nature Genetics|December 9, 2014
BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrenceLei Gu, Sandra C Frommel, Christopher C Oakes, et al.
Diagnostic Pathology|May 3, 2019
SNW1 is a prognostic biomarker in prostate cancerDoris Höflmayer, Carla Willich, Claudia Hube-Magg, et al.
Genes, Chromosomes & Cancer|January 24, 2026
PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder CarcinomasMartina Kluth, Henning Plage, Kira Furlano, et al.
International Journal of Molecular Sciences|February 2, 2017
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate CancerNathaniel Melling, Masoud Rashed, Cornelia Schroeder, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
Pageof 50

Showing results (341-350 of 495) with videos related to

Sort By:
Pageof 50
Urologic Oncology|April 4, 2020
Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancerTill Eichenauer, Luca Simmendinger, Martina Kluth, et al.
Oncotarget|March 23, 2019
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancerTill Eichenauer, Mohammad Hussein, Claudia Hube-Magg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 13, 2019
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancerFranziska Büscheck, Maciej Zub, Asmus Heumann, et al.
Nature Genetics|December 9, 2014
BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrenceLei Gu, Sandra C Frommel, Christopher C Oakes, et al.
Diagnostic Pathology|May 3, 2019
SNW1 is a prognostic biomarker in prostate cancerDoris Höflmayer, Carla Willich, Claudia Hube-Magg, et al.
Genes, Chromosomes & Cancer|January 24, 2026
PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder CarcinomasMartina Kluth, Henning Plage, Kira Furlano, et al.
International Journal of Molecular Sciences|February 2, 2017
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate CancerNathaniel Melling, Masoud Rashed, Cornelia Schroeder, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
Pageof 50